Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH): Obtained the drug registration certificate for freeze-dried human rabies vaccine (Vero cells).
Baiyunshan (600332.SH) announced that recently, Baiyunshan Biopharmaceutical Co., Ltd., a company within the scope of the consolidated financial statements, received the "Drug Registration Certificate" issued by the National Medical Products Administration for the rabies vaccine (Vero cells) for human use.
Guangzhou Baiyunshan Pharmaceutical Holdings (600332.SH) announced that recently, Guangzhou Baiyunshan Pharmaceutical Holdings Biological Products Co., Ltd. (referred to as "Guangzhou Baiyunshan Pharmaceutical Holdings Biological") within the scope of the consolidated financial statements received approval from the National Medical Products Administration to issue the "Drug Registration Certificate" for the freeze-dried human rabies vaccine (Vero cell).
The freeze-dried human rabies vaccine (Vero cell) is used to prevent rabies. Rabies is an acute infectious disease caused by the rabies virus, mainly transmitted through bites and scratches from animals carrying the rabies virus such as dogs and cats. Vaccination with the rabies vaccine is an effective way to control and prevent rabies.
Related Articles

Long Jian Road & Bridge(600853.SH): a consortium wins the bid for a 6.12 billion yuan engineering project.

Chengdu Xiling Power Science & Technology Incorporated (300733.SZ) actual controller Yu Yinglian plans to reduce its shareholding by no more than 2%

Jiangsu Chengxing Phosph-Chemicals (600078.SH): The Jiangyin factory will officially cease production fully starting from January 24, 2026.
Long Jian Road & Bridge(600853.SH): a consortium wins the bid for a 6.12 billion yuan engineering project.

Chengdu Xiling Power Science & Technology Incorporated (300733.SZ) actual controller Yu Yinglian plans to reduce its shareholding by no more than 2%

Jiangsu Chengxing Phosph-Chemicals (600078.SH): The Jiangyin factory will officially cease production fully starting from January 24, 2026.

RECOMMEND





